Home

Peter Heerma, Chief Commercial Officer: Travere Therapeutics TVTX Sell · Filed 02/03

Trade details

Type
Insider sale
Amount
$234,797.2
Shares · price
7,310 sh · $32.12 a share
Held after
131,823 sh
Trade date
26/02/03
Filed
26/02/03
Days to filing
0 days

Sold 5.3% of holdings

Share of holding sold
5.3%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 01/04~03/05

Peter Heerma's recent trades

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $525.7K

    Filed 09/17

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $10.8M

    Filed 09/16

  • Peter Heerma

    Planned sale10b5-1 planTravere Therapeutics

    $6.7M

    Filed 09/15

  • Peter Heerma

    SellTravere Therapeutics

    $101.4K

    Filed 05/06

  • Peter Heerma

    Planned saleTravere Therapeutics

    $101.4K

    Filed 05/05